HITOSHISUZUKI UrayasushiJapan

• Welcome & Introduction
  HITOSHISUZUKI Speaker Japan
• Understanding IgA Nephropathy Worldwide: Presentation, Progression, and Epidemiology
  ShikhaWadhwani Speaker shikha.wadhwani@northwestern.eduUnited States
• Mechanistic insights: Exploring the Role of Complement in IgA Nephropathy
  Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom
• Panel Discussion and Q&A Session & Closing Remarks
  HITOSHISUZUKI Speaker Japan

• Overview of Unmet Need in IgA Nephropathy and Disease Markers
  AdrianLiew Speaker draliew2@gmail.comSingapore
• Emerging Therapeutics Targets in IgAN: The Role of BAFF and APRIL
  SuceenaAlexander Speaker suceena@gmail.comIndia
• Targeting BAFF and APRIL with Atacicept
  RichardLafayette Speaker czar@stanford.eduUnited States

• Intro + IgAN Case: Global Perspective
  BradRovin Speaker rovin.1@osu.eduUnited States
• IgAN Case: China Perspective
  HongZhang Speaker China
• IgAN Case: Japan Perspective
  HITOSHISUZUKI Speaker Japan

• Tonsillectomy for IgA nephropathy
  MikiTakahara Speaker miki@asahikawa-med.ac.jpJapan
• Impact of Intestinal Barrier Dysfunction on IgA Deposition in the Glomeruli
  KojiHase Speaker hase.a6@keio.jpJapan